PTGS2 and COVID-19: At present, a number of studies have also confirmed that PTGS2 is a potential target for the treatment of COVID‐19, and it has great potential as a target for the development of new drugs (Li, Li, et al., 2021; Li, Qiu, et al., 2021; Passos et al., 2022).